| Identification of novel DNA gyrase B inhibitors in Mycobacterium species using integrated computational approaches.
doi:10.3389/ftubr.2026.1854329
|
Front Tuberc |
2026 |
| Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis.
doi:10.3389/fcimb.2026.1881444
|
Front Cell Infect Microbiol |
2026 |
| Genetic surveillance of first- and second-line drug-resistant isolates of Mycobacterium tuberculosis in Peru.
doi:10.1371/journal.pone.0352881
|
PLoS One |
2026 |
| Rapid Detection of Resistance Mutations in Multidrug-Resistant Tuberculosis With GenoType MTBDRsl Assay.
doi:10.1155/pm/6993694
|
Pulm Med |
2026 |
| Assessing Corynebacterium glutamicum as a surrogate of Mycobacterium tuberculosis for DNA gyrase inhibitor design.
doi:10.64898/2026.06.24.734172
|
bioRxiv |
2026 |
| Gemifloxacin resistance in Mycobacterium tuberculosis without QRDR mutations in gyrA or gyrB: evidence for non-canonical resistance mechanisms.
doi:10.1128/spectrum.03710-25
names it
|
Microbiol Spectr |
2026 |
| Fluoroquinolones as the linchpin of tuberculosis therapy: contrasting efficacy and resistance profiles in Mycobacterium tuberculosis versus Mycobacterium abscessus.
doi:10.3389/fcimb.2026.1833650
|
Front Cell Infect Microbiol |
2026 |
| Assessing fluoroquinolone resistance in Mycobacterium tuberculosis using nanopore sequencing: concordance with established diagnostic methods.
doi:10.1007/s15010-026-02798-8
|
Infection |
2026 |
| Exploring Novel Gene Mutations Associated with Fluoroquinolone Resistance in Mycobacterium tuberculosis: Gene Sequencing Results from 275 Clinical Isolates in Chongqing, China.
doi:10.2147/IDR.S590990
|
Infect Drug Resist |
2026 |
| Genomic investigation of Mycobacterium bovis in bulk unpasteurized dairy products in Ardabil Province, Iran.
doi:10.1038/s41598-026-47419-4
|
Sci Rep |
2026 |
| Frequency, genetic mechanisms and factors associated with fluoroquinolone (pre-XDR) and aminoglycoside resistance among multidrug-resistant tuberculosis cases in Northwestern Nigeria.
doi:10.1186/s12879-026-13191-z
|
BMC Infect Dis |
2026 |
| First report of fatal feline pulmonary tuberculosis caused by the emerging zoonotic pathogen Mycobacterium orygis in a cat from India.
doi:10.1007/s11259-026-11115-5
|
Vet Res Commun |
2026 |
| In Vitro Activity of Zoliflodacin Against Neisseria gonorrhoeae Isolates from Shanghai, China (2020-2023).
doi:10.3390/antibiotics15010061
|
Antibiotics (Basel) |
2026 |
| Molecular modelling and structure-activity relationship of pyrrolo[2,3-d]pyrimidine derivatives as potent DNA gyrase B inhibitors.
doi:10.1080/07391102.2025.2597995
|
J Biomol Struct Dyn |
2026 |
| Machine learning approaches to predict drug resistance in tuberculosis.
doi:10.1016/j.compbiolchem.2025.108705
|
Comput Biol Chem |
2026 |
| Artificial intelligence for screening drug resistance in tuberculosis.
doi:10.25259/IJMR_1546_2025
|
Indian J Med Res |
2025 |
| A novel one-tube nested fluorescence melting curve analysis for rapid detection of drug-resistant Mycobacterium tuberculosis.
doi:10.1186/s12866-025-04601-4
|
BMC Microbiol |
2025 |
| Fluoroquinolone and Second-Line Injectable Resistance Among Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates: A Molecular Study from a High-Burden Setting.
doi:10.3390/microorganisms13112470
|
Microorganisms |
2025 |
| Indole-containing inhibitors with improved efficacy targeting the gyrase of Mycobacterium tuberculosis.
doi:10.1093/narmme/ugae027
|
NAR Mol Med |
2025 |
| Succinylation of GyrB Is a Mechanism Conferring Fluoroquinolone Resistance.
doi:10.1021/acsinfecdis.5c00781
names it
|
ACS Infect Dis |
2025 |
| Mutations in gyrA and gyrB among drug-resistant Mycobacterium tuberculosis isolates in South Korea.
doi:10.1016/j.meegid.2025.105849
names it
|
Infect Genet Evol |
2025 |
| Antimicrobial susceptibility patterns and genotypic characteristics of Mycobacterium marinum and Mycobacterium abscessus isolated from cutaneous infections: A retrospective study.
doi:10.1016/j.jgar.2025.10.001
|
J Glob Antimicrob Resist |
2025 |
| Deciphering the Role of pafBC in Mycobacteriophage Resistance and Biofilm Formation.
doi:10.1021/acsinfecdis.5c00627
|
ACS Infect Dis |
2025 |
| Genomic insights into pyrazinamide and fluoroquinolone resistance in multidrug-resistant tuberculosis in Khyber Pakhtunkhwa, Pakistan.
doi:10.1016/j.ijmm.2025.151674
|
Int J Med Microbiol |
2025 |
| Diagnostics and new treatment regimens for TB: can the Xpert MTB/XDR assay fill the gap for fluoroquinolone testing?
doi:10.1128/jcm.00643-25
|
J Clin Microbiol |
2025 |
| Computational analysis of Phanera sirindhorniae flavonoids as potential inhibitors of Mycobacterium tuberculosis DNA gyrase ATPase.
doi:10.1016/j.compbiomed.2025.110991
|
Comput Biol Med |
2025 |
| Discovery of Putative GyrB Inhibitors against Mycobacterium tuberculosis: A Combined Virtual Screening and Experimental Study.
doi:10.2174/0109298673374736250527040516
names it
|
Curr Med Chem |
2025 |
| An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens.
doi:10.1186/s12890-025-03747-1
|
BMC Pulm Med |
2025 |
| The mutant selection window of moxifloxacin and bedaquiline resistant Mycobacterium tuberculosis.
doi:10.1016/j.jinf.2025.106523
|
J Infect |
2025 |
| Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil.
doi:10.1128/aac.01550-24
|
Antimicrob Agents Chemother |
2025 |
| Detection of a Mixed-Strain Infection with Drug- and Multidrug-Resistant Mycobacterium avium Subspecies hominissuis in a Dog with Generalized Lymphadenomegaly.
doi:10.3390/antibiotics14040416
|
Antibiotics (Basel) |
2025 |
| Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam.
doi:10.1111/tmi.14104
|
Trop Med Int Health |
2025 |
| Elucidating specific interactions for designing novel pyrrolamide derivatives as potential GyrB inhibitors based on ab initio fragment molecular orbital calculations.
doi:10.1080/07391102.2023.2291178
names it
|
J Biomol Struct Dyn |
2025 |
| Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing.
doi:10.1186/s12864-024-10909-8
|
BMC Genomics |
2024 |
| New generation fluoroquinolone sitafloxacin could potentially overcome the majority levofloxacin and moxifloxacin resistance in multidrug-resistant Mycobacterium tuberculosis.
doi:10.1099/jmm.0.001825
|
J Med Microbiol |
2024 |
| Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against Mycobacterium tuberculosis and Hit Validation by Biological Assays.
doi:10.1021/acs.jcim.4c00511
|
J Chem Inf Model |
2024 |
| Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates.
doi:10.1016/j.heliyon.2024.e31959
|
Heliyon |
2024 |
| Signal Propagation in the ATPase Domain of Mycobacterium tuberculosis DNA Gyrase from Dynamical-Nonequilibrium Molecular Dynamics Simulations.
doi:10.1021/acs.biochem.4c00161
|
Biochemistry |
2024 |
| Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
doi:10.1371/journal.pone.0301210
|
PLoS One |
2024 |
| Identification of novel resistance-associated mutations and discrimination within whole-genome sequences of fluoroquinolone-resistant Mycobacterium tuberculosis isolates.
doi:10.1128/spectrum.03930-23
|
Microbiol Spectr |
2024 |
| Revealing the Interaction Mechanism between Mycobacterium tuberculosis GyrB and Novobiocin, SPR719 through Binding Thermodynamics and Dissociation Kinetics Analysis.
doi:10.3390/ijms25073764
names it
|
Int J Mol Sci |
2024 |
| Efflux pump effects on levofloxacin resistance in Mycobacterium abscessus.
doi:10.1128/aac.01348-23
|
Antimicrob Agents Chemother |
2024 |
| Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
doi:10.1093/jac/dkae075
|
J Antimicrob Chemother |
2024 |
| Identification and molecular characterization of Mycobacterium bovis DNA in GeneXpert® MTB/RIF ultra-positive, culture-negative sputum from a rural community in South Africa.
doi:10.1016/j.onehlt.2024.100702
|
One Health |
2024 |
| Resolving the polycistronic aftermath: Essential role of topoisomerase IA in preventing R-loops in Leishmania.
doi:10.1016/j.jbc.2024.107162
|
J Biol Chem |
2024 |
| Genetic stability of Mycobacterium abscessus during antibiotic treatment.
doi:10.1016/j.jgar.2023.12.004
|
J Glob Antimicrob Resist |
2024 |
| Single-tube protocol for culture-independent spoligotyping of Mycobacterium tuberculosis based on MeltArray.
doi:10.1128/jcm.01183-23
|
J Clin Microbiol |
2024 |
| The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data.
doi:10.1016/j.jiph.2023.11.018
|
J Infect Public Health |
2024 |
| Computational investigation of phytochemicals identified from medicinal plant extracts against tuberculosis.
doi:10.1080/07391102.2023.2213341
|
J Biomol Struct Dyn |
2024 |
| Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
doi:10.1371/journal.pone.0294677
|
PLoS One |
2023 |
| Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China.
doi:10.1016/j.heliyon.2023.e21216
|
Heliyon |
2023 |
| Whole genome sequencing-based identification of human tuberculosis caused by animal-lineage Mycobacterium orygis.
doi:10.1128/jcm.00260-23
|
J Clin Microbiol |
2023 |
| GYRB - POLYMERASE CHAIN REACTION AND HISTOPATHOLOGIC CHARACTERISTIC FIGURE POTENTIAL FOR DETERMINING DIAGNOSIS OF TUBERCULOUS LYMPHADENITIS.
doi:10.21010/Ajidv17i2S.3
names it
|
Afr J Infect Dis |
2023 |
| Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the Mycobacteria Growth Indicator Tube 960 system.
doi:10.4103/ijmy.ijmy_144_23
|
Int J Mycobacteriol |
2023 |
| Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
doi:10.1016/j.jmii.2023.08.013
|
J Microbiol Immunol Infect |
2023 |
| Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
doi:10.1016/j.ijtb.2022.11.004
|
Indian J Tuberc |
2023 |
| Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage.
doi:10.1016/j.jiph.2023.07.016
|
J Infect Public Health |
2023 |
| Characterization of Genetic Mutations in Multi-Drug-Resistant Isolates of Mycobacterium tuberculosis Bacilli Conferring Resistance to a Second-Line Anti-tuberculosis Drug.
doi:10.7759/cureus.40442
|
Cureus |
2023 |
| Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep.
doi:10.1016/j.ebiom.2023.104649
|
EBioMedicine |
2023 |
| Comparison of the Diagnostic Performance of MeltPro and Next-Generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Isolates.
doi:10.1016/j.jmoldx.2023.02.003
|
J Mol Diagn |
2023 |
| Distinct subunit architecture and assembly pattern of DNA gyrase from mycobacteria.
doi:10.1111/mmi.15068
|
Mol Microbiol |
2023 |
| Strain diversity in Mycobacterium avium subsp. paratuberculosis-positive bovine fecal samples collected in Switzerland.
doi:10.3389/fvets.2023.1154516
|
Front Vet Sci |
2023 |
| Isoflavonoid and Furanochromone Natural Products as Potential DNA Gyrase Inhibitors: Computational, Spectral, and Antimycobacterial Studies.
doi:10.1021/acsomega.3c00684
|
ACS Omega |
2023 |
| Bioisosteric Design Identifies Inhibitors of Mycobacterium tuberculosis DNA Gyrase ATPase Activity.
doi:10.1021/acs.jcim.2c01376
|
J Chem Inf Model |
2023 |
| Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
doi:10.1128/spectrum.05088-22
|
Microbiol Spectr |
2023 |
| Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
doi:10.1128/jcm.01478-22
|
J Clin Microbiol |
2023 |
| GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory.
doi:10.1016/j.diagmicrobio.2022.115856
|
Diagn Microbiol Infect Dis |
2023 |
| Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study.
doi:10.1080/20477724.2022.2049029
|
Pathog Glob Health |
2023 |
| Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001.
doi:10.3389/fcimb.2022.1056007
|
Front Cell Infect Microbiol |
2022 |
| An In-Silico Evaluation of Anthraquinones as Potential Inhibitors of DNA Gyrase B of Mycobacterium tuberculosis.
doi:10.3390/microorganisms10122434
|
Microorganisms |
2022 |
| Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil.
doi:10.3389/fvets.2022.1006090
|
Front Vet Sci |
2022 |
| High diversity of clinical Mycobacterium intracellulare in China revealed by whole genome sequencing.
doi:10.3389/fpubh.2022.989587
|
Front Public Health |
2022 |
| Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance.
doi:10.3390/cimb44090283
|
Curr Issues Mol Biol |
2022 |
| Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
doi:10.1371/journal.pone.0267320
|
PLoS One |
2022 |
| Evaluation of the diagnostic value of loop-mediated isothermal amplification assays targeting three different Mycobacterium tuberculosis genes.
doi:10.1016/j.mimet.2022.106547
|
J Microbiol Methods |
2022 |
| Molecular Surveillance of Antimicrobial Resistance of Mycobacterium leprae from Leprosy Patients in Zhejiang Province, China.
doi:10.2147/IDR.S368682
|
Infect Drug Resist |
2022 |
| Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
doi:10.1016/S2666-5247(22)00117-3
|
Lancet Microbe |
2022 |
| [Exploratory study on detection of drug resistance of Mycobacterium tuberculosis in sputum specimens by next-generation sequencing].
doi:10.3760/cma.j.cn112147-20211104-00775
|
Zhonghua Jie He He Hu Xi Za Zhi |
2022 |
| Potential therapeutic targets from Mycobacterium abscessus (Mab): recently reported efforts towards the discovery of novel antibacterial agents to treat Mab infections.
doi:10.1039/d1md00359c
|
RSC Med Chem |
2022 |
| Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China.
doi:10.2147/IDR.S361635
|
Infect Drug Resist |
2022 |
| Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in M. tuberculosis Clinical Isolates from Western and Northern India.
doi:10.2147/IDR.S345855
|
Infect Drug Resist |
2022 |
| Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.
doi:10.1186/s12879-022-07339-w
|
BMC Infect Dis |
2022 |
| Use of a gyrB PCR-RFLP method to diagnose tuberculosis and identify the causative Mycobacterium sp. in cattle and humans.
doi:10.1016/j.cimid.2022.101767
names it
|
Comp Immunol Microbiol Infect Dis |
2022 |
| Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.
doi:10.1128/spectrum.01475-21
|
Microbiol Spectr |
2022 |
| In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus.
doi:10.1128/spectrum.01321-21
|
Microbiol Spectr |
2022 |
| Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis.
doi:10.1089/mdr.2021.0212
|
Microb Drug Resist |
2022 |
| Intradermal comparative cervical tuberculin test in the diagnosis of caprine tuberculosis.
doi:10.1007/s42770-021-00650-9
|
Braz J Microbiol |
2022 |
| Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
doi:10.1128/Spectrum.00409-21
|
Microbiol Spectr |
2021 |
| Correlation of gyr Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh.
doi:10.3390/pathogens10111422
|
Pathogens |
2021 |
| The pipeline of new molecules and regimens against drug-resistant tuberculosis.
doi:10.1016/j.jctube.2021.100285
|
J Clin Tuberc Other Mycobact Dis |
2021 |
| Mycobacterium microti Infection in Wild Boar (Sus scrofa): Histopathology Analysis Suggests Containment of the Infection.
doi:10.3389/fvets.2021.734919
|
Front Vet Sci |
2021 |
| Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole-genome sequencing.
doi:10.1016/j.ijid.2021.09.028
|
Int J Infect Dis |
2021 |
| First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections.
doi:10.1128/AAC.01208-21
names it
|
Antimicrob Agents Chemother |
2021 |
| Simultaneous Determination of Mycobacterium leprae Drug Resistance and Single-Nucleotide Polymorphism Genotype by Use of Nested Multiplex PCR with Amplicon Sequencing.
doi:10.1128/JCM.00814-21
|
J Clin Microbiol |
2021 |
| Quantification of pathogens and antibiotic resistance genes in backyard and commercial composts.
doi:10.1016/j.scitotenv.2021.149197
|
Sci Total Environ |
2021 |
| A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
doi:10.1016/j.cmi.2021.07.007
|
Clin Microbiol Infect |
2021 |
| Highly specific and sensitive detection of the Mycobacterium tuberculosis complex using multiplex loop-mediated isothermal amplification combined with a nanoparticle-based lateral flow biosensor.
doi:10.1007/s42770-021-00520-4
|
Braz J Microbiol |
2021 |
| Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance.
doi:10.1016/j.ijantimicag.2021.106385
|
Int J Antimicrob Agents |
2021 |
| Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
doi:10.1038/s41598-021-91757-4
|
Sci Rep |
2021 |
| Interaction of Quinolones Carrying New R1 Group with Mycobacterium leprae DNA Gyrase.
doi:10.1089/mdr.2020.0408
|
Microb Drug Resist |
2021 |
| Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis.
doi:10.1016/j.csbj.2021.04.034
|
Comput Struct Biotechnol J |
2021 |
| Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.
doi:10.1128/AAC.00676-21
|
Antimicrob Agents Chemother |
2021 |
| Loop-mediated isothermal amplification (LAMP) assay targeting RLEP for detection of Mycobacterium leprae in leprosy patients.
doi:10.1016/j.ijid.2021.04.041
|
Int J Infect Dis |
2021 |
| Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.
doi:10.1038/s41598-021-87516-0
|
Sci Rep |
2021 |
| Molecular Characteristics and Drug Resistance of Mycobacterium tuberculosis Isolate Circulating in Shaanxi Province, Northwestern China.
doi:10.1089/mdr.2020.0496
|
Microb Drug Resist |
2021 |
| Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco.
doi:10.1590/S1678-9946202163019
|
Rev Inst Med Trop Sao Paulo |
2021 |
| Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey.
doi:10.1016/j.jinf.2021.02.004
|
J Infect |
2021 |
| Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
doi:10.1371/journal.pntd.0009068
|
PLoS Negl Trop Dis |
2021 |
| Genotyping and Molecular Characterization of Fluoroquinolone's Resistance Among Multidrug-Resistant Mycobacterium tuberculosis in Southwest of China.
doi:10.1089/mdr.2019.0339
|
Microb Drug Resist |
2021 |
| Emergence of Specific gyrA Mutations Associated High-Level Fluoroquinolone-Resistant Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Cases in North India.
doi:10.1089/mdr.2020.0240
|
Microb Drug Resist |
2021 |
| Resistance-Conferring Mutations on Whole-Genome Sequencing of Fluoroquinolone-resistant and -Susceptible Mycobacterium tuberculosis Isolates: A Proposed Threshold for Identifying Resistance.
doi:10.1093/cid/ciaa496
|
Clin Infect Dis |
2021 |
| Isolation, Molecular Typing, and Antibiotic Susceptibility Testing of Mycobacterium avium Subspecies hominissuis From a Dog With Generalized Mycobacteriosis.
doi:10.3389/fvets.2020.569966
|
Front Vet Sci |
2020 |
| Structure-Based Screening of DNA GyraseB Inhibitors for Therapeutic Applications in Tuberculosis: a Pharmacoinformatics Study.
doi:10.1007/s12010-020-03374-y
|
Appl Biochem Biotechnol |
2020 |
| Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species.
doi:10.1038/s41598-020-65766-8
|
Sci Rep |
2020 |
| Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
doi:10.1186/s12879-020-05112-5
|
BMC Infect Dis |
2020 |
| Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India.
doi:10.4103/ijmr.IJMR_493_18
|
Indian J Med Res |
2020 |
| Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
doi:10.1590/0074-02760200055
|
Mem Inst Oswaldo Cruz |
2020 |
| Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.
doi:10.1186/s12890-020-1172-4
|
BMC Pulm Med |
2020 |
| Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears.
doi:10.1371/journal.pone.0232343
|
PLoS One |
2020 |
| Artificial Intelligence and Machine learning based prediction of resistant and susceptible mutations in Mycobacterium tuberculosis.
doi:10.1038/s41598-020-62368-2
|
Sci Rep |
2020 |
| Advancement of GyrB Inhibitors for Treatment of Infections Caused by Mycobacterium tuberculosis and Non-tuberculous Mycobacteria.
doi:10.1021/acsinfecdis.0c00025
names it
|
ACS Infect Dis |
2020 |
| Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India.
doi:10.1093/trstmh/trz121
|
Trans R Soc Trop Med Hyg |
2020 |
| Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing.
doi:10.1038/s41598-020-57992-x
|
Sci Rep |
2020 |
| Functional interactions between gyrase subunits are optimized in a species-specific manner.
doi:10.1074/jbc.RA119.010245
|
J Biol Chem |
2020 |
| Diagnostic accuracy of droplet digital PCR analysis of cerebrospinal fluid for tuberculous meningitis in adult patients.
doi:10.1016/j.cmi.2019.07.015
|
Clin Microbiol Infect |
2020 |
| Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs.
doi:10.5588/ijtld.18.0562
|
Int J Tuberc Lung Dis |
2019 |
| Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China.
doi:10.21037/jtd.2019.11.03
|
J Thorac Dis |
2019 |
| Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification.
doi:10.3390/antibiotics8040247
|
Antibiotics (Basel) |
2019 |
| Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
doi:10.1038/s41598-019-51562-6
|
Sci Rep |
2019 |
| Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients.
doi:10.1080/22221751.2019.1677177
|
Emerg Microbes Infect |
2019 |
| In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase: HQSAR, CoMSIA and molecular dynamics simulations.
doi:10.1080/1062936X.2019.1658218
names it
|
SAR QSAR Environ Res |
2019 |
| A multilocus sequence typing scheme for Mycobacterium abscessus complex (MAB-multilocus sequence typing) using whole-genome sequencing data.
doi:10.4103/ijmy.ijmy_106_19
|
Int J Mycobacteriol |
2019 |
| Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
doi:10.2147/IDR.S209971
|
Infect Drug Resist |
2019 |
| Three-reaction high-resolution melting assay for rapid differentiation of Mycobacterium tuberculosis complex members.
doi:10.1002/mbo3.919
|
Microbiologyopen |
2019 |
| Mutation and Transmission Profiles of Second-Line Drug Resistance in Clinical Isolates of Drug-Resistant Mycobacterium tuberculosis From Hebei Province, China.
doi:10.3389/fmicb.2019.01838
|
Front Microbiol |
2019 |
| DNA gyrase could be a crucial regulatory factor for growth and survival of Mycobacterium leprae.
doi:10.1038/s41598-019-47364-5
|
Sci Rep |
2019 |
| Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
doi:10.1186/s12890-019-0891-x
|
BMC Pulm Med |
2019 |
| Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
doi:10.1016/j.jiac.2019.05.028
|
J Infect Chemother |
2019 |
| Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
doi:10.1016/j.jgar.2019.03.012
|
J Glob Antimicrob Resist |
2019 |
| Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
doi:10.1186/s12879-019-3911-9
|
BMC Infect Dis |
2019 |
| Development of a new High Resolution Melting (HRM) assay for identification and differentiation of Mycobacterium tuberculosis complex samples.
doi:10.1038/s41598-018-38243-6
|
Sci Rep |
2019 |
| Overall Structures of Mycobacterium tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity.
doi:10.1016/j.str.2019.01.004
names it
|
Structure |
2019 |
| Mutational analysis of gyrB at amino acids: G481A & D505A in multidrug resistant (MDR) tuberculosis patients.
doi:10.1016/j.jiph.2019.01.056
names it
|
J Infect Public Health |
2019 |
| Pharmacophore modeling and molecular dynamics approach to identify putative DNA Gyrase B inhibitors for resistant tuberculosis.
doi:10.1002/jcb.27579
|
J Cell Biochem |
2019 |
| Design of novel quinoline-aminopiperidine derivatives as Mycobacterium tuberculosis (MTB) GyrB inhibitors: an in silico study.
doi:10.1080/07391102.2018.1498806
names it
|
J Biomol Struct Dyn |
2019 |
| rpoB Targeted Loop-Mediated Isothermal Amplification (LAMP) Assay for Consensus Detection of Mycobacteria Associated With Pulmonary Infections.
doi:10.3389/fmed.2018.00332
|
Front Med (Lausanne) |
2018 |
| Chemical classes targeting energy supplying GyrB domain of Mycobacterium tuberculosis.
doi:10.1016/j.tube.2018.09.001
names it
|
Tuberculosis (Edinb) |
2018 |
| Rewired Downregulation of DNA Gyrase Impacts Cell Division, Expression of Topology Modulators, and Transcription in Mycobacterium smegmatis.
doi:10.1016/j.jmb.2018.10.001
|
J Mol Biol |
2018 |
| Description of a novel species of fast growing mycobacterium: Mycobacterium kyogaense sp. nov., a scotochromogenic strain received as Mycobacterium vaccae.
doi:10.1099/ijsem.0.003039
|
Int J Syst Evol Microbiol |
2018 |
| In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis.
doi:10.1016/j.tube.2018.08.005
|
Tuberculosis (Edinb) |
2018 |
| Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates.
doi:10.1128/AAC.00527-18
names it
|
Antimicrob Agents Chemother |
2018 |
| Recent progress in the discovery and development of DNA gyrase B inhibitors.
doi:10.4155/fmc-2017-0257
|
Future Med Chem |
2018 |
| Regulation of the gyr operon of Mycobacterium tuberculosis by overlapping promoters, DNA topology, and reiterative transcription.
doi:10.1016/j.bbrc.2018.05.067
|
Biochem Biophys Res Commun |
2018 |
| Single-nucleotide polymorphisms related to fluoroquinolone and aminoglycoside resistance in Mycobacterium avium isolates.
doi:10.2147/IDR.S160899
|
Infect Drug Resist |
2018 |
| Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.
doi:10.1016/S1473-3099(18)30073-2
|
Lancet Infect Dis |
2018 |
| Diagnostic accuracy of GenoType(®) MTBDRsl VER 2.0 in detecting second-line drug resistance to M. tuberculosis.
doi:10.5588/ijtld.17.0663
|
Int J Tuberc Lung Dis |
2018 |
| Performance of Sequencing in Predicting Ofloxacin Resistance in Mycobacterium tuberculosis from Positive Bactec MGIT 960 Cultures.
|
Ann Clin Lab Sci |
2018 |
| Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case.
doi:10.2147/IDR.S152720
|
Infect Drug Resist |
2018 |
| Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
doi:10.1186/s12879-018-3009-9
|
BMC Infect Dis |
2018 |
| Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.
doi:10.1128/AAC.01788-17
|
Antimicrob Agents Chemother |
2018 |
| Genotypic detection of fluoroquinolone resistance in drug-resistant Mycobacterium tuberculosis at a tertiary care centre in south Coastal Karnataka, India.
doi:10.1016/j.jgar.2018.01.023
|
J Glob Antimicrob Resist |
2018 |
| In Vitro Activity and MIC of Sitafloxacin against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Isolated in Thailand.
doi:10.1128/AAC.00825-17
|
Antimicrob Agents Chemother |
2018 |
| Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
doi:10.1016/j.jgar.2017.10.003
names it
|
J Glob Antimicrob Resist |
2018 |
| Molecular characteristics of ofloxacin mono-resistant Mycobacterium tuberculosis isolates from new and previously treated tuberculosis patients.
doi:10.1002/jcla.22202
|
J Clin Lab Anal |
2018 |
| Mutation analysis for detection of drug resistance in mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan.
|
J Pak Med Assoc |
2017 |
| Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
doi:10.1093/cid/cix556
|
Clin Infect Dis |
2017 |
| Mycobacterium orygis Lymphadenitis in New York, USA.
doi:10.3201/eid2310.170490
|
Emerg Infect Dis |
2017 |
| Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
doi:10.1056/NEJMoa1614915
|
N Engl J Med |
2017 |
| Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates.
doi:10.3389/fmicb.2017.01539
|
Front Microbiol |
2017 |
| In Silico Prediction of Antibiotic Resistance in Mycobacterium ulcerans Agy99 through Whole Genome Sequence Analysis.
doi:10.4269/ajtmh.16-0478
|
Am J Trop Med Hyg |
2017 |
| High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
doi:10.1016/j.ijantimicag.2017.04.010
|
Int J Antimicrob Agents |
2017 |
| Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.
doi:10.1128/AAC.01921-16
names it
|
Antimicrob Agents Chemother |
2017 |
| In vitro activity of sitafloxacin against Mycobacterium tuberculosis with gyrA/B mutations isolated in Japan.
doi:10.1099/jmm.0.000493
|
J Med Microbiol |
2017 |
| Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?
doi:10.1093/jac/dkx150
|
J Antimicrob Chemother |
2017 |
| Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.
doi:10.1093/jac/dkx110
|
J Antimicrob Chemother |
2017 |
| Double Mutants in DNA Gyrase Lead to Ofloxacin Resistance in Mycobacterium tuberculosis.
doi:10.1002/jcb.25954
|
J Cell Biochem |
2017 |
| Identification of promising DNA GyrB inhibitors for Tuberculosis using pharmacophore-based virtual screening, molecular docking and molecular dynamics studies.
doi:10.1111/cbdd.12949
names it
|
Chem Biol Drug Des |
2017 |
| FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance.
doi:10.1128/JCM.01662-16
|
J Clin Microbiol |
2017 |
| Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa.
doi:10.1128/JCM.01865-16
|
J Clin Microbiol |
2017 |
| Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.
doi:10.1128/JCM.01771-16
|
J Clin Microbiol |
2017 |
| Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
doi:10.1016/j.meegid.2016.09.012
|
Infect Genet Evol |
2017 |
| Pre-Multidrug-Resistant Mycobacterium tuberculosis Infection Causing Fatal Enteric Disease in a Dog from a Family with History of Human Tuberculosis.
doi:10.1111/tbed.12513
|
Transbound Emerg Dis |
2017 |
| Alternate efflux pump mechanism may contribute to drug resistance in extensively drug-resistant isolates of Mycobacterium tuberculosis.
doi:10.1016/j.ijmyco.2016.09.064
|
Int J Mycobacteriol |
2016 |
| A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.
doi:10.1371/journal.pone.0167093
|
PLoS One |
2016 |
| Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania.
doi:10.1016/j.diagmicrobio.2016.08.026
|
Diagn Microbiol Infect Dis |
2016 |
| Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
doi:10.1371/journal.pntd.0005041
|
PLoS Negl Trop Dis |
2016 |
| Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.
doi:10.1128/AAC.00664-16
|
Antimicrob Agents Chemother |
2016 |
| Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
doi:10.1016/j.ejmech.2016.08.034
names it
|
Eur J Med Chem |
2016 |
| Digital PCR assay detection of circulating Mycobacterium tuberculosis DNA in pulmonary tuberculosis patient plasma.
doi:10.1016/j.tube.2016.04.004
|
Tuberculosis (Edinb) |
2016 |
| The Chromosomal parDE2 Toxin-Antitoxin System of Mycobacterium tuberculosis H37Rv: Genetic and Functional Characterization.
doi:10.3389/fmicb.2016.00886
|
Front Microbiol |
2016 |
| Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.
doi:10.1128/JCM.00670-16
names it
|
J Clin Microbiol |
2016 |
| Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.
doi:10.1128/AAC.00393-16
|
Antimicrob Agents Chemother |
2016 |
| Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
doi:10.1128/AAC.00539-16
names it
|
Antimicrob Agents Chemother |
2016 |
| Quantification of colony-forming units for M. tuberculosis complex using gyrB-based real-time PCR assay.
doi:10.5588/ijtld.15.0473
names it
|
Int J Tuberc Lung Dis |
2016 |
| Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
doi:10.1128/JCM.00051-16
|
J Clin Microbiol |
2016 |
| Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray.
doi:10.1093/jac/dkw015
|
J Antimicrob Chemother |
2016 |
| Mycobacterium sherrisii visceral disseminated infection in an African HIV-infected adolescent.
doi:10.1016/j.ijid.2016.02.011
|
Int J Infect Dis |
2016 |
| Structure-Guided Discovery of Antitubercular Agents That Target the Gyrase ATPase Domain.
doi:10.1002/cmdc.201500556
|
ChemMedChem |
2016 |
| Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
doi:10.1128/AAC.01049-15
names it
|
Antimicrob Agents Chemother |
2016 |
| Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
doi:10.1128/JCM.02775-15
|
J Clin Microbiol |
2016 |
| Molecular characterization and drug susceptibility profile of a Mycobacterium avium subspecies avium isolate from a dog with disseminated infection.
doi:10.1099/jmm.0.000221
|
J Med Microbiol |
2016 |
| Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea.
doi:10.5588/ijtld.15.0068
|
Int J Tuberc Lung Dis |
2016 |
| Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? Mycobacterium tuberculosis novel bacterial topoisomerase inhibitors.
doi:10.1016/j.bmc.2015.11.039
|
Bioorg Med Chem |
2016 |
| Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.
doi:10.1093/jac/dkv360
|
J Antimicrob Chemother |
2016 |
| Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China.
doi:10.1038/ja.2015.106
|
J Antibiot (Tokyo) |
2016 |
| Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
doi:10.1016/j.jmii.2015.04.003
|
J Microbiol Immunol Infect |
2016 |
| Spatiotemporal and Ecological Patterns of Mycobacterium microti Infection in Wild Boar (Sus scrofa).
doi:10.1111/tbed.12313
|
Transbound Emerg Dis |
2016 |
| [Detection of mutations in the gyrA and gyrB genes associated with fluoroquinolone-resistance among clinical isolates of Mycobacterium abscessus in China].
names it
|
Zhonghua Jie He He Hu Xi Za Zhi |
2015 |
| Molecular characterization of Mycobacterium orygis isolates from wild animals of Nepal.
|
Jpn J Vet Res |
2015 |
| 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.
doi:10.1016/j.ejmech.2015.06.032
names it
|
Eur J Med Chem |
2015 |
| Proteomic analysis of ofloxacin-mono resistant Mycobacterium tuberculosis isolates.
doi:10.1016/j.jprot.2015.07.031
|
J Proteomics |
2015 |
| Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
doi:10.1371/journal.pone.0120470
names it
|
PLoS One |
2015 |
| Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors.
doi:10.1016/j.bmc.2015.03.004
|
Bioorg Med Chem |
2015 |
| Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.
doi:10.1016/j.bmc.2015.02.032
names it
|
Bioorg Med Chem |
2015 |
| Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
doi:10.1371/journal.pone.0117771
|
PLoS One |
2015 |
| Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes.
doi:10.1128/mBio.02273-14
|
mBio |
2015 |
| Low resistance to first and second line anti-tuberculosis drugs among treatment naive pulmonary tuberculosis patients in southwestern Uganda.
doi:10.1371/journal.pone.0118191
|
PLoS One |
2015 |
| Evaluation of a low-density hydrogel microarray technique for mycobacterial species identification.
doi:10.1128/JCM.02579-14
|
J Clin Microbiol |
2015 |
| Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
doi:10.1016/j.ejmech.2015.01.013
|
Eur J Med Chem |
2015 |
| Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling.
doi:10.1039/c4ob02049a
|
Org Biomol Chem |
2015 |
| Detailed investigation of the microbial community in foaming activated sludge reveals novel foam formers.
doi:10.1038/srep07637
|
Sci Rep |
2015 |
| Exploring the gyrase ATPase domain for tailoring newer anti-tubercular drugs: hit to lead optimization of a novel class of thiazole inhibitors.
doi:10.1016/j.bmc.2014.12.001
|
Bioorg Med Chem |
2015 |
| Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
doi:10.1128/AAC.04058-14
|
Antimicrob Agents Chemother |
2015 |
| Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China.
doi:10.1016/j.ijantimicag.2014.09.018
|
Int J Antimicrob Agents |
2015 |
| Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase.
doi:10.1177/1087057114554170
|
J Biomol Screen |
2015 |
| Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
doi:10.1038/ja.2014.95
|
J Antibiot (Tokyo) |
2015 |
| The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
doi:10.1128/microbiolspec.MGM2-0009-2013
|
Microbiol Spectr |
2014 |
| [Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip].
|
Mol Biol (Mosk) |
2014 |
| An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.
doi:10.1016/j.bmc.2014.10.016
names it
|
Bioorg Med Chem |
2014 |
| Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studies.
doi:10.2174/1568026613666140929123833
names it
|
Curr Top Med Chem |
2014 |
| Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis.
doi:10.2147/IDR.S65417
|
Infect Drug Resist |
2014 |
| Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
doi:10.1186/1471-2334-14-478
|
BMC Infect Dis |
2014 |
| Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation.
doi:10.1002/minf.201400058
|
Mol Inform |
2014 |
| [Heteroresistance in Mycobacteria tuberculosis is an important factor for the inconsistency between the results of phenotype and genotype drug susceptibility tests].
|
Zhonghua Jie He He Hu Xi Za Zhi |
2014 |
| Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues.
doi:10.1002/cmdc.201402035
|
ChemMedChem |
2014 |
| Amycolatopsis roodepoortensis sp. nov. and Amycolatopsis speibonae sp. nov.: antibiotic-producing actinobacteria isolated from South African soils.
doi:10.1038/ja.2014.79
|
J Antibiot (Tokyo) |
2014 |
| Detection and molecular characterization of Mycobacterium microti isolates in wild boar from northern Italy.
doi:10.1128/JCM.00440-14
|
J Clin Microbiol |
2014 |
| Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China.
doi:10.1128/AAC.02426-14
|
Antimicrob Agents Chemother |
2014 |
| MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis.
doi:10.1186/1471-2105-15-107
|
BMC Bioinformatics |
2014 |
| High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
doi:10.1128/AAC.02066-13
names it
|
Antimicrob Agents Chemother |
2014 |
| Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis.
doi:10.1038/emi.2014.21
|
Emerg Microbes Infect |
2014 |
| Isolation of Mycobacterium caprae (Lechtal genotype) from red deer (Cervus elaphus) in Italy.
doi:10.7589/2013-06-135
|
J Wildl Dis |
2014 |
| Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
doi:10.1074/jbc.M113.529164
|
J Biol Chem |
2014 |
| Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leads.
doi:10.1016/j.ijantimicag.2013.12.006
|
Int J Antimicrob Agents |
2014 |
| Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
doi:10.1128/AAC.01792-13
|
Antimicrob Agents Chemother |
2014 |
| Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy.
doi:10.1016/j.bmcl.2013.12.080
|
Bioorg Med Chem Lett |
2014 |
| Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.
doi:10.1128/JCM.02701-13
|
J Clin Microbiol |
2014 |
| Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China.
doi:10.1128/AAC.01228-13
|
Antimicrob Agents Chemother |
2014 |
| Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis.
doi:10.1128/AAC.01751-13
names it
|
Antimicrob Agents Chemother |
2014 |
| Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.
doi:10.1093/jac/dkt358
|
J Antimicrob Chemother |
2014 |
| Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis.
doi:10.1128/JCM.00857-13
|
J Clin Microbiol |
2014 |
| Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.
doi:10.1016/j.ejmech.2013.09.025
names it
|
Eur J Med Chem |
2013 |
| Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.
doi:10.1021/jm401268f
|
J Med Chem |
2013 |
| Identification of the likely translational start of Mycobacterium tuberculosis GyrB.
doi:10.1186/1756-0500-6-274
names it
|
BMC Res Notes |
2013 |
| Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis.
doi:10.1128/AAC.00506-13
|
Antimicrob Agents Chemother |
2013 |
| Determination of critical concentrations of moxifloxacin and gatifloxacin for drug susceptibility testing of Mycobacterium tuberculosis in the BACTEC MGIT 960 system.
doi:10.1093/jac/dkt202
|
J Antimicrob Chemother |
2013 |
| Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.
doi:10.1186/1471-2334-13-240
|
BMC Infect Dis |
2013 |
| Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
doi:10.1016/j.tube.2013.02.005
|
Tuberculosis (Edinb) |
2013 |
| Region of difference 4 in alpine Mycobacterium caprae isolates indicates three variants.
doi:10.1128/JCM.02966-12
|
J Clin Microbiol |
2013 |
| The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action.
doi:10.1074/jbc.M112.419069
|
J Biol Chem |
2013 |
| Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis.
doi:10.1021/cb300510w
names it
|
ACS Chem Biol |
2013 |
| Bacterial classification of fish-pathogenic Mycobacterium species by multigene phylogenetic analyses and MALDI Biotyper identification system.
doi:10.1007/s10126-012-9492-x
|
Mar Biotechnol (NY) |
2013 |
| Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
doi:10.1099/jmm.0.046821-0
names it
|
J Med Microbiol |
2013 |
| Rapid tests for the detection of the Mycobacterium abscessus subsp. bolletii strain responsible for an epidemic of surgical-site infections in Brazil.
doi:10.1590/s0074-02762012000800002
|
Mem Inst Oswaldo Cruz |
2012 |
| Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
doi:10.1371/journal.pntd.0001838
|
PLoS Negl Trop Dis |
2012 |
| Binding of two DNA molecules by type II topoisomerases for decatenation.
doi:10.1093/nar/gks843
|
Nucleic Acids Res |
2012 |
| Popular molecular markers in bacteria.
|
Mol Gen Mikrobiol Virusol |
2012 |
| Rapid and accurate identification of Mycobacterium tuberculosis complex and common non-tuberculous mycobacteria by multiplex real-time PCR targeting different housekeeping genes.
doi:10.1007/s00284-012-0188-2
|
Curr Microbiol |
2012 |
| New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
doi:10.1371/journal.pone.0039754
names it
|
PLoS One |
2012 |
| Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
doi:10.1016/j.diagmicrobio.2012.03.025
|
Diagn Microbiol Infect Dis |
2012 |
| Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China.
doi:10.1128/JCM.06860-11
|
J Clin Microbiol |
2012 |
| Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
doi:10.1016/s1413-8670(12)70294-5
names it
|
Braz J Infect Dis |
2012 |
| Human Tuberculous Meningitis Caused by Mycobacterium caprae.
doi:10.1159/000337299
|
Case Rep Neurol |
2012 |
| gyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China.
doi:10.1016/j.ijantimicag.2012.02.015
|
Int J Antimicrob Agents |
2012 |
| Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
doi:10.1016/j.ijantimicag.2012.01.007
|
Int J Antimicrob Agents |
2012 |
| Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing.
doi:10.1128/AAC.05905-11
|
Antimicrob Agents Chemother |
2012 |
| Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
doi:10.1128/AAC.06272-11
names it
|
Antimicrob Agents Chemother |
2012 |
| A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
doi:10.1093/jac/dkr566
|
J Antimicrob Chemother |
2012 |
| Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
doi:10.5588/ijtld.10.0600
|
Int J Tuberc Lung Dis |
2012 |
| The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services.
doi:10.5588/ijtld.11.0223
|
Int J Tuberc Lung Dis |
2012 |
| High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.
doi:10.1128/JCM.05286-11
|
J Clin Microbiol |
2012 |
| Detection and discrimination of Mycobacterium tuberculosis complex.
doi:10.1016/j.diagmicrobio.2011.09.021
|
Diagn Microbiol Infect Dis |
2012 |
| Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.
doi:10.1093/jac/dkr449
|
J Antimicrob Chemother |
2012 |
| Phenotypic and molecular characterization of quinolone resistance in Mycobacterium abscessus subsp. bolletii recovered from postsurgical infections.
doi:10.1099/jmm.0.034942-0
|
J Med Microbiol |
2012 |
| gyrA and gyrB gene mutation in ciprofloxacin-resistant Mycobacterium massiliense clinical isolates from Southern Brazil.
doi:10.1089/mdr.2011.0047
names it
|
Microb Drug Resist |
2012 |
| gyrA and gyrB mutations in ofloxacin-resistant Mycobacterium tuberculosis clinical isolates in Thailand.
names it
|
Southeast Asian J Trop Med Public Health |
2011 |
| Pyrosequencing assay for rapid identification of Mycobacterium tuberculosis complex species.
doi:10.1186/1756-0500-4-423
|
BMC Res Notes |
2011 |
| Species distribution of the Mycobacterium tuberculosis complex in clinical isolates from 2007 to 2010 in Turkey: a prospective study.
doi:10.1128/JCM.01172-11
|
J Clin Microbiol |
2011 |
| Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan.
doi:10.1128/AAC.05101-11
|
Antimicrob Agents Chemother |
2011 |
| Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report.
doi:10.3343/kjlm.2011.31.3.197
|
Korean J Lab Med |
2011 |
| DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
doi:10.1128/AAC.00707-11
names it
|
Antimicrob Agents Chemother |
2011 |
| The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage.
doi:10.1093/nar/gkr553
names it
|
Nucleic Acids Res |
2011 |
| Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas.
doi:10.1128/JCM.00231-11
|
J Clin Microbiol |
2011 |
| Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
doi:10.1128/AAC.00042-11
names it
|
Antimicrob Agents Chemother |
2011 |
| Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings.
doi:10.1128/JCM.01889-10
|
J Clin Microbiol |
2011 |
| [Isolation and identification of a pyrene-degrading bacterial strain from contaminated soil].
|
Wei Sheng Wu Xue Bao |
2011 |
| Genotyping of Mycobacterium leprae from Brazilian leprosy patients suggests the occurrence of reinfection or of bacterial population shift during disease relapse.
doi:10.1099/jmm.0.029389-0
|
J Med Microbiol |
2011 |
| Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.
doi:10.1128/JCM.00197-11
|
J Clin Microbiol |
2011 |
| Population-based investigation of fluoroquinolones resistant tuberculosis in rural eastern China.
doi:10.1016/j.tube.2011.03.001
|
Tuberculosis (Edinb) |
2011 |
| Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009.
doi:10.1186/1471-2334-11-78
|
BMC Infect Dis |
2011 |
| Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.
doi:10.1128/JCM.00113-11
|
J Clin Microbiol |
2011 |
| Multiplexed typing of Mycobacterium avium subsp. paratuberculosis types I, II, and III by Luminex xMAP suspension array.
doi:10.1128/JCM.01761-10
|
J Clin Microbiol |
2011 |
| [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates].
|
Zhonghua Jie He He Hu Xi Za Zhi |
2010 |
| Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model.
doi:10.1128/AAC.00968-10
|
Antimicrob Agents Chemother |
2010 |
| [Molecular characterization of drug-resistant and extensive-drug resistant isolates of Mycobacterium tuberculosis in Shenzhen of China].
|
Zhonghua Jie He He Hu Xi Za Zhi |
2010 |
| Identification of Mycobacterium tuberculosis clinical isolates in Bangladesh by a species distinguishable multiplex PCR.
doi:10.1186/1471-2334-10-118
|
BMC Infect Dis |
2010 |
| Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China.
doi:10.1016/j.jinf.2010.05.001
names it
|
J Infect |
2010 |
| Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
doi:10.1128/JCM.01947-09
|
J Clin Microbiol |
2010 |
| Differentiation of clinical Mycobacterium tuberculosis complex isolates by their GyrB polymorphism.
doi:10.4103/0255-0857.58724
names it
|
Indian J Med Microbiol |
2010 |
| Gold nanoprobe assay for the identification of mycobacteria of the Mycobacterium tuberculosis complex.
doi:10.1111/j.1469-0691.2009.03120.x
|
Clin Microbiol Infect |
2010 |
| First report of molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates from a Tunisian hospital.
doi:10.1111/j.1469-0691.2009.03087.x
|
Clin Microbiol Infect |
2010 |
| A novel and more sensitive loop-mediated isothermal amplification assay targeting IS6110 for detection of Mycobacterium tuberculosis complex.
doi:10.1016/j.micres.2009.05.001
|
Microbiol Res |
2010 |
| [Species-specific detection of Mycobacterium tuberculosis complex].
|
Tuberk Biolezni Legkih |
2009 |
| Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.
doi:10.1128/AAC.00541-09
|
Antimicrob Agents Chemother |
2009 |
| Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
doi:10.1128/AAC.00287-09
names it
|
Antimicrob Agents Chemother |
2009 |
| Unique genotypes of Mycobacterium avium subsp. paratuberculosis strains of Type III.
doi:10.1016/j.vetmic.2009.06.011
|
Vet Microbiol |
2009 |
| Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.
doi:10.1128/AAC.00050-09
|
Antimicrob Agents Chemother |
2009 |
| [Differentiation of species within the Mycobacterium tuberculosis complex by molecular techniques].
doi:10.1016/j.eimc.2009.01.008
|
Enferm Infecc Microbiol Clin |
2009 |
| Crystallization and preliminary crystallographic studies of Mycobacterium tuberculosis DNA gyrase B C-terminal domain, part of the enzyme reaction core.
doi:10.1107/S1744309109006575
|
Acta Crystallogr Sect F Struct Biol Cryst Commun |
2009 |
| Molecular detection of drug-resistant Mycobacterium tuberculosis with a scanning-frame oligonucleotide microarray.
doi:10.1007/978-1-59745-207-6_26
|
Methods Mol Biol |
2009 |
| Mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent HIV infection in Mozambique.
doi:10.1590/s1806-37132008001000011
|
J Bras Pneumol |
2008 |
| A single-step sequencing method for the identification of Mycobacterium tuberculosis complex species.
doi:10.1371/journal.pntd.0000253
|
PLoS Negl Trop Dis |
2008 |
| Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia.
doi:10.1128/AAC.00036-08
|
Antimicrob Agents Chemother |
2008 |
| [Rd7 genotyping of M. tuberculosis strains isolated from patients with lung tuberculosis in different areas of Kazakhstan].
|
Mol Gen Mikrobiol Virusol |
2008 |
| Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
doi:10.1128/AAC.01380-07
names it
|
Antimicrob Agents Chemother |
2008 |
| Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?
doi:10.1128/AAC.01095-07
|
Antimicrob Agents Chemother |
2008 |
| Mycobacterium tuberculosis DNA gyrase as a target for drug discovery.
doi:10.2174/187152607781001763
|
Infect Disord Drug Targets |
2007 |
| Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
doi:10.1159/000109769
|
Chemotherapy |
2007 |
| Characterization of Mycobacterium africanum subtype I among cows in a dairy farm in Bangladesh using spoligotyping.
|
Southeast Asian J Trop Med Public Health |
2007 |
| [Detection of Mycobacterium species distribution in the sputum samples of tuberculosis patients by PCR-RFLP method in Elazig province].
|
Mikrobiyol Bul |
2007 |
| Polymorphisms in gyrA and gyrB genes among Mycobacterium avium subsp. paratuberculosis type I, II, and III isolates.
doi:10.1128/JCM.01411-07
names it
|
J Clin Microbiol |
2007 |
| Refractory osteomyelitis caused by bacille Calmette-Guérin vaccination: a case report.
doi:10.1016/j.diagmicrobio.2007.04.011
|
Diagn Microbiol Infect Dis |
2007 |
| Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance.
doi:10.1007/s10096-007-0298-0
names it
|
Eur J Clin Microbiol Infect Dis |
2007 |
| Diversity of environmental Mycobacterium isolates from hemodialysis water as shown by a multigene sequencing approach.
doi:10.1128/AEM.02934-06
|
Appl Environ Microbiol |
2007 |
| Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
doi:10.1093/jac/dkm061
|
J Antimicrob Chemother |
2007 |
| Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
doi:10.1128/AAC.01282-06
|
Antimicrob Agents Chemother |
2007 |
| A microbial diagnostic microarray technique for the sensitive detection and identification of pathogenic bacteria in a background of nonpathogens.
doi:10.1016/j.ab.2006.09.026
|
Anal Biochem |
2007 |
| Genomic diversity in Mycobacterium avium: single nucleotide polymorphisms between the S and C strains of M. avium subsp. paratuberculosis and with M. a. avium.
doi:10.1016/j.mcp.2006.08.002
|
Mol Cell Probes |
2007 |
| Study of the gyrB gene polymorphism as a tool to differentiate among Mycobacterium tuberculosis complex subspecies further underlines the older evolutionary age of 'Mycobacterium canettii'.
doi:10.1016/j.mcp.2005.11.008
names it
|
Mol Cell Probes |
2006 |
| Comparative study of two typing methods, hsp65 PRA and ITS sequencing, revealed a possible evolutionary link between Mycobacterium kansasii type I and II isolates.
doi:10.1111/j.1574-6968.2005.00013.x
|
FEMS Microbiol Lett |
2006 |
| Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
doi:10.1128/AAC.50.1.104-112.2006
|
Antimicrob Agents Chemother |
2006 |
| [Microbiological and molecular analysis of mycobacterium tuberculosis complex strains isolated from patients with pulmonary tuberculosis].
|
Pneumonol Alergol Pol |
2005 |
| Spoligotyping and pncA polymorphism: a two step scenario for Mycobacterium bovis diagnosis in Portugal.
doi:10.1016/s0873-2159(15)30528-6
|
Rev Port Pneumol |
2005 |
| Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand.
names it
|
Southeast Asian J Trop Med Public Health |
2005 |
| Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.
doi:10.1093/jac/dki353
|
J Antimicrob Chemother |
2005 |
| A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism.
doi:10.1093/nar/gki622
|
Nucleic Acids Res |
2005 |
| Mycobacterium tuberculosis complex differentiation using gyrB-restriction fragment length polymorphism analysis.
doi:10.1590/s0074-02762004000700014
names it
|
Mem Inst Oswaldo Cruz |
2004 |
| [Comparison of two reverse hybridization methods for mycobacterial identification in clinical practice].
doi:10.1016/j.patbio.2004.07.018
|
Pathol Biol (Paris) |
2004 |
| The species Mycobacterium africanum in the light of new molecular markers.
doi:10.1128/JCM.42.9.3958-3962.2004
|
J Clin Microbiol |
2004 |
| [Molecular identification of mycobacteria and detection of antibiotic resistance].
|
Ann Biol Clin (Paris) |
2004 |
| Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.
doi:10.1128/AAC.48.4.1281-1288.2004
|
Antimicrob Agents Chemother |
2004 |
| Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov.
doi:10.1099/ijs.0.02532-0
|
Int J Syst Evol Microbiol |
2003 |
| Mycobacterium bovis subsp. caprae caused one-third of human M. bovis-associated tuberculosis cases reported in Germany between 1999 and 2001.
doi:10.1128/JCM.41.7.3070-3077.2003
|
J Clin Microbiol |
2003 |
| Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples.
doi:10.1128/JCM.41.6.2616-2622.2003
|
J Clin Microbiol |
2003 |
| Detection and identification of Mycobacterium species isolates by DNA microarray.
doi:10.1128/JCM.41.6.2605-2615.2003
|
J Clin Microbiol |
2003 |
| Detection of gene mutations related with drug resistance in Mycobacterium leprae from leprosy patients using Touch-Down (TD) PCR.
doi:10.1016/S0928-8244(03)00038-5
|
FEMS Immunol Med Microbiol |
2003 |
| Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.
doi:10.1128/JCM.41.3.1311-1315.2003
|
J Clin Microbiol |
2003 |
| An orphan gyrB in the Mycobacterium smegmatis genome uncovered by comparative genomics.
doi:10.1007/BF02715907
names it
|
J Genet |
2002 |
| DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters.
doi:10.1128/JB.184.19.5449-5456.2002
|
J Bacteriol |
2002 |
| Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore.
doi:10.1016/s1201-9712(02)90136-0
|
Int J Infect Dis |
2002 |
| Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase.
doi:10.1093/nar/30.10.2144
|
Nucleic Acids Res |
2002 |
| Biochemical and genetic evidence for the transfer of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to the species Mycobacterium bovis Karlson and Lessel 1970 (approved lists 1980) as Mycobacterium bovis subsp. caprae comb. nov.
doi:10.1099/00207713-52-2-433
|
Int J Syst Evol Microbiol |
2002 |
| Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India.
doi:10.1128/AAC.46.2.443-450.2002
|
Antimicrob Agents Chemother |
2002 |
| A Mycobacterium smegmatis gyrase B specific monoclonal antibody reveals association of gyrase A and B subunits in the cell.
doi:10.1111/j.1574-6968.2001.tb09451.x
|
FEMS Microbiol Lett |
2001 |
| Differentiation of clinical Mycobacterium tuberculosis complex isolates by gyrB DNA sequence polymorphism analysis.
doi:10.1128/JCM.38.9.3231-3234.2000
names it
|
J Clin Microbiol |
2000 |
| Differentiation of phylogenetically related slowly growing mycobacteria by their gyrB sequences.
doi:10.1128/JCM.38.1.301-308.2000
names it
|
J Clin Microbiol |
2000 |
| Regulation of DNA gyrase operon in Mycobacterium smegmatis: a distinct mechanism of relaxation stimulated transcription.
doi:10.1046/j.1365-2443.1999.00296.x
|
Genes Cells |
1999 |
| Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.
doi:10.1128/AAC.42.8.2084
|
Antimicrob Agents Chemother |
1998 |
| Gene arrangement and organization in a approximately 76 kb fragment encompassing the oriC region of the chromosome of Mycobacterium leprae.
doi:10.1099/13500872-142-11-3147
|
Microbiology (Reading) |
1996 |
| Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.
doi:10.1128/AAC.40.9.2054
|
Antimicrob Agents Chemother |
1996 |
| Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
doi:10.1128/AAC.40.8.1768
|
Antimicrob Agents Chemother |
1996 |
| Organization of the origins of replication of the chromosomes of Mycobacterium smegmatis, Mycobacterium leprae and Mycobacterium tuberculosis and isolation of a functional origin from M. smegmatis.
doi:10.1111/j.1365-2958.1996.tb02617.x
|
Mol Microbiol |
1996 |
| Mycobacterium smegmatis DNA gyrase: cloning and overexpression in Escherichia coli.
doi:10.1099/13500872-141-12-3029
|
Microbiology (Reading) |
1995 |
| Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994.
doi:10.2165/00003495-199500492-00006
|
Drugs |
1995 |
| Molecular cloning of gyrA and gyrB genes of Mycobacterium tuberculosis: analysis of nucleotide sequence.
names it
|
Biochem Mol Biol Int |
1994 |
| Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.
doi:10.1128/AAC.38.4.773
names it
|
Antimicrob Agents Chemother |
1994 |